ICICI Prudential Nifty Pharma Index Fund

Request a Callback
Are you an existing investor of ICICI Prudential Mutual Fund?

+ 91 -
Detect Me
  • {{city.Title}}

Submit in {{otpseconds}} secs

OTP has been sent on

Change number

Thank you for your details.

We will get in touch with you shortly

Meanwhile you can explore various schemes offered by us

You will be re-directed to the home page in {{seconds}}s

About ICICI Prudential Nifty Pharma Index Fund

The pharmaceutical sector has been growing exponentially and is significantly contributing to the increasing
life expectancy rate in India. From the development and production of generic drugs, OTC medicines, vaccines
to contract research & manufacturing, this sector carries out a wide range of activities.
In fact, it is the 3rd largest industry worldwide in terms of volume and 14th by value. Now, seeking an opportunity
to benefit from this tremendously progressive industry might not be a bad idea, right?
Introducing ICICI Prudential Nifty Pharma Index Fund, an open ended index fund that seeks to track returns by investing
in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error.

How does this scheme work?

• This scheme replicates the Nifty Pharma Index.
• The index reflects the behavior and performance
of the companies that are engaged into manufacturing of
pharmaceuticals and biotechnology companies.
• The stock weight is analysed and rebalanced semi-annually,
in the month of January and July.

Why should you invest in this scheme?

Economic Drivers

With increasing demand for healthcare, medicines and health insurances the sector seems to be progressing.


Factors like low cost of production and R&D boosts efficiency, which also leads to competitive exports.

Change in lifestyle

People are now aware and cautious about their health problems. They have access to facilities like insurance and preventive healthcare, which would further boost the industry.

Government Support

As per the Union Budget 2022-23, US$ 4.83 billion has been allocated to the 'National Health Mission’.

Who should invest in this scheme?

If you’re interested to participate in the growth story of the pharmaceutical industry and aim to fulfill your long term goals, this scheme is good for you!

Key Features

Scheme Name ICICI Prudential Nifty Pharma Index Fund
NFO Period25th November, 2022 to 9th December 2022
Scheme Type An open ended index scheme replicating Nifty Pharma Index
Plans/ OptionsPlans: Regular & Direct
Options: Growth & IDCW (IDCW Payout & IDCW Reinvestment)
Exit LoadNil
The Trustees shall have a right to prescribe or modify the exit load structure with prospective effect subject to a maximum prescribed under the Regulations.
Minimum Application Amount, including switchesDURING NEW FUND OFFER PERIOD/ DURING ONGOING OFFER PERIOD:
Rs.1000/- (plus in multiple of Re.1)
Minimum application amount for switch-ins: Rs. 1000/- and any amount thereafter
Minimum Additional Application Amount, including switchesRs.1000/- (plus in multiple of Re.1) Minimum additional application amount for switch ins – Rs. 1000/- and any amount thereafter.
· Daily, Weekly, Fortnightly, Monthly SIP$: Rs. 1000/- (plus in multiple of Re. 1/-) Minimum installments: 6
· Quarterly SIP$: Rs. 5,000/- (plus in multiple of Re. 1/-) Minimum installments – 4
$The applicability of the minimum amount of installment mentioned is at the time of registration only
BenchmarkNifty Pharma TRI
ListingBeing an open ended scheme, the Units of the Scheme will not be listed on any stock exchange, at present.
Fund ManagerKayzad Eghlim and Nishit Patel

For details of other schemes managed by the same fund managers, click here.

You can now read more about our ICICI Prudential Nifty Pharma Index Fund Presentation

Disclaimer of NSE Indices Limited (NSE Indices) The Product(s) are not sponsored, endorsed, sold or promoted by NSE Indices Limited (" NSE Indices"). NSE Indices does not make any representation or warranty, express or implied, to the owners of the Product(s) or any member of the public regarding the advisability of investing in securities generally or in the Product(s) particularly or the ability of the Nifty Pharma Index to track general stock market performance in India. The relationship of NSE Indices to the Issuer is only in respect of the licensing of certain trademarks and trade names of its Index which is determined, composed and calculated by NSE Indices without regard to the Issuer or the Product(s). NSE Indices does not have any obligation to take the needs of the Issuer or the owners of the Product(s) into consideration in determining, composing or calculating the Nifty Pharma Index. NSE Indices is not responsible for or has participated in the determination of the timing of, prices at, or quantities of the Product(s) to be issued or in the determination or calculation of the equation by which the Product(s) is to be converted into cash. NSE Indices has no obligation or liability in connection with the administration, marketing or trading of the Product(s). NSE Indices do not guarantee the accuracy and/or the completeness of the Nifty Pharma Index or any data included therein and they shall have no liability for any errors, omissions, or interruptions therein. NSE Indices does not make any warranty, express or implied, as to results to be obtained by the Issuer, owners of the product(s), or any other person or entity from the use of the Nifty Pharma Index or any data included therein. NSE Indices makes no express or implied warranties, and expressly disclaim all warranties of merchantability or fitness for a particular purpose or use with respect to the index or any data included therein. Without limiting any of the foregoing, NSE Indices expressly disclaim any and all liability for any damages or losses arising out of or related to the Products, including any and all direct, special, punitive, indirect, or consequential damages (including lost profits), even if notified of the possibility of such damages.
ICICI ETF is part of ICICI Prudential Mutual Fund and is used for exchange traded funds managed by ICICI Prudential Asset Management Company Limited.
Mutual Fund investments are subject to market risks, please read all scheme related documents carefully.